Posenacaftor sodium
Posenacaftor (PTI-801) sodium 是一种囊性纤维化跨膜调节蛋白 (CFTR) 调节剂，可纠正 CFTR 蛋白的折叠和运输。Posenacaftor sodium 用于囊性纤维化 (CF) 的研究。
此产品仅用于科学研究，我们不为任何个人用途提供产品和服务
-
包装价格促销价数量
-
5mg￥5175.004140.00- +
-
10mg￥8637.006910.00- +
-
25mg￥17625.0014100.00- +
-
50mg￥27787.0022230.00- +
-
100mg￥42750.0034200.00- +
- 货号: ajcx33888
- CAS: 2095064-06-3
- 别名: PTI-801 sodium
- 分子式: C27H26NNaO5
- 分子量: 467.49
- 纯度: ＞98%
- 溶解度: DMSO : 200 mg/mL (427.82 mM; Need ultrasonic)
- 储存: Store at -20°C
- 库存: 现货
Background
Posenacaftor (PTI-801) sodium is a cystic fibrosis transmembrane regulator (CFTR) protein modulator that corrects the folding and trafficking of CFTR protein. Posenacaftor sodium is used for the research of cystic fibrosis (CF)[1].
Cystic fibrosis (CF) is an autosomal recessive disorder, caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR)[1].CFTR is a cAMP-regulated chloride channel that is primarily located at the apical membrane of epithelial cells.Mutations in the CFTR gene lead to the production of a defective and misfolded CFTR protein, and impairs the flow of ions in and out of cells[1].Posenacaftor is a CFTR corrector, correctors are always designed to fix and restore the function of the defective CFTR protein. The corrected CFTR then moves to the cell surface, where it functions as a chloride channel and helps maintain the right balance of fluid in the airways[2].
[1]. Benjamin Kopp, et al. Compositions et procédés pour améliorer la fonction cftr dans des cellules affectées par la fibrose kystique. Patent WO2019156946.
[2]. Posenacaftor (PTI-801)
